featured
Talazoparib and Avelumab for Recurrent Mismatch Repair–Proficient Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
JAMA Oncol 2022 Jul 28;[EPub Ahead of Print], PA Konstantinopoulos, AA Gockley, N Xiong, C Krasner, N Horowitz, S Campos, AA Wright, JF Liu, M Shea, O Yeku, C Castro, M Polak, EK Lee, H Sawyer, B Bowes, J Moroney, SC Cheng, N Tayob, S Bouberhan, D Spriggs, RT Penson, GF Fleming, MR Nucci, UA MatulonisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.